NCT06409169
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
Active, Not Recruiting
NAAges 18+InterventionalTreatmentOregon Health and Science UniversityInvestigator-initiated
~141 participants
Updated 2026-06-05 on ClinicalTrials.gov
What's tested:DBS TaTUsual Care
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
HCV Treatment Initiation
Measured over 12 weeks after diagnosis of HCV
Conditions
Where it's being run
1 sites across 1 statesOregon1
Study leadership
- Hunter Spencer, DO · PRINCIPAL_INVESTIGATOR · Oregon Health and Science University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Active hepatitis C infection
Willing to engaged with the PATHS program for clinical care
What this trial measures
- HCV Treatment Initiation12 weeks after diagnosis of HCV
Rate of hepatitis C (HCV) treatment initiation in sites utilizing DBS TaT versus sites utilizing usual care.